DK113689D0 - Cellespecifikke cytotoksiske midler samt fremgangsmaade til fremstilling deraf - Google Patents

Cellespecifikke cytotoksiske midler samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK113689D0
DK113689D0 DK113689A DK113689A DK113689D0 DK 113689 D0 DK113689 D0 DK 113689D0 DK 113689 A DK113689 A DK 113689A DK 113689 A DK113689 A DK 113689A DK 113689 D0 DK113689 D0 DK 113689D0
Authority
DK
Denmark
Prior art keywords
cell
cytotoxic agents
specific cytotoxic
production procedures
procedures
Prior art date
Application number
DK113689A
Other languages
English (en)
Other versions
DK113689A (da
Inventor
Clarence L Villemez
Dean A Myers
Original Assignee
Univ Wyoming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wyoming filed Critical Univ Wyoming
Publication of DK113689D0 publication Critical patent/DK113689D0/da
Publication of DK113689A publication Critical patent/DK113689A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK113689A 1988-03-08 1989-03-08 Cellespecifikke cytotoksiske midler samt fremgangsmaade til fremstilling deraf DK113689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16521388A 1988-03-08 1988-03-08

Publications (2)

Publication Number Publication Date
DK113689D0 true DK113689D0 (da) 1989-03-08
DK113689A DK113689A (da) 1989-09-09

Family

ID=22597941

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113689A DK113689A (da) 1988-03-08 1989-03-08 Cellespecifikke cytotoksiske midler samt fremgangsmaade til fremstilling deraf

Country Status (7)

Country Link
EP (1) EP0332174A3 (da)
JP (1) JPH0215099A (da)
AU (1) AU632995B2 (da)
CA (1) CA1340612C (da)
DK (1) DK113689A (da)
IL (1) IL89504A0 (da)
PT (1) PT89927A (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
JP3311346B2 (ja) * 1990-03-02 2002-08-05 ボストン・メディカル・センター・コーポレーション 改良されたキメラ毒素
NO175188C (no) * 1990-06-27 1994-09-14 Sjur Olsnes Fremgangsmåte for fremstilling av et peptidkonjugat med evne til å trenge inn i cellecytosol
US5858363A (en) * 1990-07-20 1999-01-12 Pharmacia & Upjohn Ab Target specific antibody-superantigen conjugates and their preparation
HU218603B (hu) * 1990-07-20 2000-10-28 Kabi Pharmacia Ab Célspecifikus antitest-szuperantigén konjugátumok és ezen készítmények előállítása
BR9205967A (pt) * 1991-05-03 1994-07-26 Seragen Inc Moléculas marcadas com receptor de interleucina tratamento de artrite inflamatória
WO1993021769A1 (en) * 1992-05-06 1993-11-11 President And Fellows Of Harvard College Diphtheria toxin receptor-binding region
US7696338B2 (en) 1995-10-30 2010-04-13 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin fusion proteins and means for expression thereof
US7288254B2 (en) 1995-10-30 2007-10-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Nih Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
US6632928B1 (en) 1997-03-05 2003-10-14 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxins and methods of inducing immune tolerance
US7517527B2 (en) 1995-10-30 2009-04-14 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin with in vivo T cell suppressant activity and methods of use
US7125553B1 (en) 1996-04-15 2006-10-24 The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention Methods of inducing immune tolerance using immunotoxins
AU736501B2 (en) * 1997-03-05 2001-07-26 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel vectors and expression methods for producing mutant proteins
JP7041414B2 (ja) 2018-10-31 2022-03-24 Smc株式会社 電磁弁

Also Published As

Publication number Publication date
AU632995B2 (en) 1993-01-21
CA1340612C (en) 1999-06-29
PT89927A (pt) 1989-11-10
DK113689A (da) 1989-09-09
IL89504A0 (en) 1989-09-10
EP0332174A3 (en) 1990-12-19
AU3110389A (en) 1989-10-12
EP0332174A2 (en) 1989-09-13
JPH0215099A (ja) 1990-01-18

Similar Documents

Publication Publication Date Title
DK147488A (da) Benzoxazolderivat samt fremgangsmaade til fremstilling deraf
DK275788A (da) Fibrinolytiske proteiner
DK113689D0 (da) Cellespecifikke cytotoksiske midler samt fremgangsmaade til fremstilling deraf
FI88815B (fi) Faestanordning foer jaernvaegsskena samt fjaederregel
DK69689A (da) Termoelement
NO173300C (no) S!kerradarsystem
BR8800883A (pt) Artigo
BR8807600A (pt) Britador giratorio
FI91488B (fi) Seula
DK84589A (da) Ekspressionsvektor
DK495188D0 (da) Ekspressionsvektor
SE8801573L (sv) Helisolerat spaennstycke
DK60890A (da) Tetrahydropyridinderivat
AT386333B (de) Artikulator
KR890018946U (ko) 드로우어웨이팁
DK354789D0 (da) Alkenyltetrazolderivater samt fremgangsmaade til fremstilling deraf
KR890000165U (ko) 귀걸이
DK192188A (da) Chalkon-derivater samt anvendelsen heraf
KR890006500U (ko) 드로우어웨이팁
KR890012275U (ko) 경운기용 배토기
DK179288D0 (da) Dioxolan- og dioxanderivater
IT216028Z2 (it) Orecchino
ATA233689A (de) Grubber
KR890008303U (ko) 귀걸이
KR880014590U (ko) 귀걸이

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment